positive
Recently
SPARC Shares Surge 20% Following US Court Ruling in Favor of PRV Issuance
SPARC shares hit a 20% upper circuit after a US court ruling favored the company in the PRV issuance for Sezaby, with further developments expected.
Shares of Sun Pharma Advanced Research Company (SPARC) surged 20%, hitting ₹161 on the National Stock Exchange and BSE, following a favorable ruling by the US District Court for the District of Columbia. The court granted SPARC’s motion for summary judgment regarding the issuance of the Priority Review Voucher (PRV) for Sezaby.